|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vancomy- cin therapeutic guidelines显示文摘 | Rybak MJ Lomaestro BM Rotscahfer JC | 2009 | Clin Infect Dis2009，49，3： | 1 |
| 2 | Pharmacodynamic evaluation of extending the administration time of meropenem using a monte carlo simulation 显示文摘 | Lomaestro BM Drusano GL | 2005 | Antimicrob Agents Chemother2005，49，1： | 1 |
| 3 | Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on 13-lactam antibiotics 显示文摘 | Lodise TP Lomaestro BM Drusano GL | 2006 | Phannacotherapy2006，26，9： | 1 |
| 4 | Therapeutic monitoring of vancomycin in adult patients :a consensus re- view of the American Society of Health-System Pharmacists , the hffectious Diseases Society of America , and the Soci- etyOfinfectious Diseases pharmacists 显示文摘 | Rybak M Lomaestro B Rotschafer JC | 2009 | Am J Health Syst Pharm2009，66，1： | 1 |
| 5 | Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmaeists,the Infectious Diseases Society of America,and the Sociely of Infectious Diseases Pharmacists显示文摘 | Rybak M Lomaestro B Rotschafer JC et a1 | 2009 | Am J Health Syst Pharm2009，66，1： | 1 |
| 6 | Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharma- cists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists 显示文摘 | Rybak M Lomaestro B Rotschafer JC | 2009 | American Journal of Health System Pharmacy2009，66，1： | 1 |
| 7 | Interaction of quinolones and cation显示文摘 | Lomaestro BM | 1991 | Drug Intell Clin Pharm1991，25，11： | 1 |
| 8 | Therapeutic monitoring of vancomycin in adult patients: a consensus re- view of the american society of health-system pharmacists, the infectious diseases society of america, and the society of infectious diseases pharmacists显示文摘 | Rybak M Lomaestro B Rotsehafer JC | 2009 | Am J Health Syst Pharm2009，66，1： | 1 |
| 9 | Therapeuticmonitoring of vancomycin in adult patients: a consensus reviewof the American Society of Health-System Pharmacists, theInfectious Diseases Society of America, and the Society ofInfectious Diseases Pharmacists显示文摘 | Rybak M Lomaestro B Rotschafer JC | 2009 | Am J Health Syst Pharm2009，66，1： | 1 |
| 10 | Application d antimicrobial phannacodynamic concepts into dinical practice: foucus on beta-lactam antibiotics: insights from the society of infectious diseases phamutcists 显示文摘 | Lodise TP Lomaestro BM Drusano GL | 2006 | Pharmacotherapy2006，26，9： | 1 |
| 11 | Drug dosing in patients undergoing continuous renal replacement therapy 显示文摘 | Vincent HT Lomaestro BM | 2001 | NY State J Healthsyst Pharmacist2001，20，1： | 1 |
| 12 | Vancomycin therapeutic guidelines : a summary of consensus recommendations from the infectious diseases society of Ameriea, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists 显示文摘 | Rybak M J Lomaestro BM Rotschafer JC | 2009 | Clin Infect Dis2009，49，3： | 1 |
| 13 | Larger van- comycin doses (at least four grams per day) are associ- ated with an increased incidence of nephrotoxieity显示文摘 | Lodise T P Lomaestro B Graves J | 2008 | Antimicrob Agents Chemother2008，52，4： | 1 |
| 14 | Therapeutic monitoring of vancomycin in adult patients : a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists 显示文摘 | Rybak M Lomaestro B Rotschafer JC | 2009 | Am J Health Syst Pharm2009，66，： | 1 |
| 15 | Piperacillin-tazobactam for Pseudomonas aeruginosa infection:clinical implications of an extended-infusion dosing strategy显示文摘 | Lodise TP Jr Lomaestro B Drusano GL | 2007 | Clin Infect Dis2007，44，3： | 1 |
| 16 | Application of antimicro bial pharmacodynamic concepts into clinical practice:Focus on ~-lac- tam antibiotics显示文摘 | Lodise T P Lomaestro B M Drusano G L | 2006 | Pharmacotherapy2006，26，9： | 1 |
| 17 | Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy 显示文摘 | Lodise TP Lomaestro B Drusano GL | 2007 | Clin Infect Dis2007，44，3： | 1 |
| 18 | Vancomycin thera- peutic guidelines:a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists and the Society of Infectious Diseases Pharmacists显示文摘 | Rybak M J Lomaestro BM Rotschafer JC | 2009 | Clin Infect Dis2009，49，： | 1 |
| 19 | Larger vancomycin doses are associated with an increased incidence of nephrotox- ticity显示文摘 | Lodise TP Lomaestro B Graves J | 2008 | Antimicrob Agents Chemother2008，52，7： | 1 |
| 20 | Therapeutic monitoring of vancomycin in adult patients : a consensus re- view of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists 显示文摘 | Rybak M Lomaestro B Rotschafer JC | 2009 | American Journal of Health-System Pharmacy2009，66，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员